The U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) will hold a joint public meeting on October 21 to discuss innovation and future control paths for smoking cessation products. The public can express their views by registering and making public comments.
The public can participate in feedback
On September 20, the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) will jointly hold a public meeting titled “Promoting Smoking Cessation: Priorities for FDA and NIH” on October 21 from 9:00 a.m. to 4:30 p.m. This conference aims to promote innovation in smoking cessation products to help adults and adolescents quit smoking.
There will be many presentations and panel discussions on smoking cessation. Topics discussed include clinical and community perspectives, promising target areas for development, and future paths for control. In addition, the conference will provide an opportunity for public comment on some related topics.
The meeting is free and open to the public. It is important to note that live participation requires registration by October 15, 2024, and the virtual method can register before 9 am registration (EDT) on the day of the conference. If you want to speak live during the public comment phase, you need to speak on October 1 at 5 pm. (EDT) before completing registration.
Written comments must be approved by Regulations by November 21, 2024. gov meeting for public documents [Docket No. FDA-2024-N-4085].
The U.S. Department of Health and Human Services (HHS) Framework for Supporting and Accelerating Smoking Cessation identifies the goals of smoking cessation research to promote continuity and innovation. The October Federation of FDA and NIH aims to support these efforts and promote joint efforts of the whole society to improve the health level in China, the organization said.
